NO20085056L - Insulinderivat - Google Patents
InsulinderivatInfo
- Publication number
- NO20085056L NO20085056L NO20085056A NO20085056A NO20085056L NO 20085056 L NO20085056 L NO 20085056L NO 20085056 A NO20085056 A NO 20085056A NO 20085056 A NO20085056 A NO 20085056A NO 20085056 L NO20085056 L NO 20085056L
- Authority
- NO
- Norway
- Prior art keywords
- insulin derivatives
- derivatives
- hyperglycemia
- methods
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Den foreliggende oppfinnelse vedrører nye menneskeinsulinderivater som er løselige ved fysiologiske pH-verdier og har en forlenget virkningsprofil. Oppfinnelsen vedrører også fremgangsmåter for å frembringe slike derivater, farmasøytiske blandinger inneholdende dem, metoder for behandling av diabetes og hyperglykemi ved bruk av insulinderivatene ifølge oppfinnelsen og anvendelse av slike insulinderivater ved behandling av diabetes og hyperglykemi.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06113709 | 2006-05-09 | ||
EP06118260 | 2006-08-01 | ||
PCT/EP2007/054444 WO2007128817A2 (en) | 2006-05-09 | 2007-05-08 | Insulin derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085056L true NO20085056L (no) | 2008-12-03 |
Family
ID=38668119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085056A NO20085056L (no) | 2006-05-09 | 2008-12-03 | Insulinderivat |
Country Status (13)
Country | Link |
---|---|
US (1) | US8933021B2 (no) |
EP (2) | EP2015770B1 (no) |
JP (1) | JP5269767B2 (no) |
KR (1) | KR101441444B1 (no) |
AU (1) | AU2007247109B2 (no) |
BR (1) | BRPI0712041A2 (no) |
CA (1) | CA2649235A1 (no) |
ES (2) | ES2548393T3 (no) |
IL (1) | IL194312A0 (no) |
MX (1) | MX2008014061A (no) |
NO (1) | NO20085056L (no) |
RU (1) | RU2451029C2 (no) |
WO (1) | WO2007128817A2 (no) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2264065B1 (en) * | 2003-08-05 | 2017-03-08 | Novo Nordisk A/S | Novel insulin derivatives |
ES2428510T3 (es) | 2005-02-02 | 2013-11-08 | Novo Nordisk A/S | Derivados de insulina |
ES2435522T3 (es) | 2005-02-02 | 2013-12-20 | Novo Nordisk A/S | Derivados de insulina |
EP2505593A1 (en) | 2005-12-28 | 2012-10-03 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
ES2387955T3 (es) * | 2006-02-27 | 2012-10-04 | Novo Nordisk A/S | Derivados de insulina |
JP5269766B2 (ja) | 2006-05-09 | 2013-08-21 | ノボ・ノルデイスク・エー/エス | インスリン誘導体 |
AU2007298919C1 (en) | 2006-09-22 | 2014-02-06 | Novo Nordisk A/S | Protease resistant insulin analogues |
US10100098B2 (en) | 2006-12-13 | 2018-10-16 | Stelis Biopharma Private Limited | Insulin production methods and proinsulin constructs |
US20120214963A1 (en) * | 2011-02-23 | 2012-08-23 | Elona Biotechnologies | Aspart proinsulin compositions and methods of producing aspart insulin analogs therefrom |
WO2008132224A2 (en) | 2007-04-30 | 2008-11-06 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
US9034818B2 (en) | 2007-06-13 | 2015-05-19 | Novo Nordisk A/S | Pharmaceutical formulations comprising an insulin derivative |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
CN101932601B (zh) | 2007-11-08 | 2016-08-03 | 诺沃-诺迪斯克有限公司 | 胰岛素衍生物 |
US8937042B2 (en) * | 2007-11-16 | 2015-01-20 | Novo Nordisk A/S | Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide |
CN101970477B (zh) | 2008-03-14 | 2014-12-31 | 诺沃-诺迪斯克有限公司 | 蛋白酶稳定的胰岛素类似物 |
PT2254906T (pt) | 2008-03-18 | 2017-01-03 | Novo Nordisk As | Análogos de insulina acilados, estabilizados contra proteases |
WO2010049488A1 (en) * | 2008-10-30 | 2010-05-06 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
ES2561658T3 (es) * | 2009-12-16 | 2016-02-29 | Novo Nordisk A/S | Derivados de GLP-1 con doble acilación |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
DE102010015123A1 (de) | 2010-04-16 | 2011-10-20 | Sanofi-Aventis Deutschland Gmbh | Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
JP6049625B2 (ja) | 2010-10-27 | 2016-12-21 | ノヴォ ノルディスク アー/エス | 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療 |
AU2011322495A1 (en) * | 2010-10-27 | 2013-04-11 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections administered with varying injection intervals |
RU2600440C3 (ru) | 2010-12-16 | 2021-12-10 | Ново Нордиск А/С | Твердые композиции, содержащие агонист glp-1 и соль n-(8-(2-гидроксибензоил)амино)каприловой кислоты |
US9447163B2 (en) | 2011-02-01 | 2016-09-20 | Novo Nordisk A/S | Purification of insulin |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012140117A1 (en) | 2011-04-12 | 2012-10-18 | Novo Nordisk A/S | Double-acylated glp-1 derivatives |
KR102093463B1 (ko) * | 2011-04-12 | 2020-03-26 | 노보 노르디스크 에이/에스 | 이중 아실화된 glp-1 유도체 |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
ES2952874T3 (es) | 2012-03-22 | 2023-11-06 | Novo Nordisk As | Composiciones de péptidos GLP-1 y preparación de estas |
DK2827845T3 (en) | 2012-03-22 | 2019-04-01 | Novo Nordisk As | COMPOSITIONS INCLUDING A PROCEDURE AND PREPARING THEREOF |
KR20150002777A (ko) | 2012-04-11 | 2015-01-07 | 노보 노르디스크 에이/에스 | 인슐린 제제 |
BR112014026442A8 (pt) | 2012-05-01 | 2018-01-16 | Novo Nordisk As | combinação para alcançar o controle glicêmico, seu uso, e composição farmacêutica. |
CN104487056A (zh) | 2012-06-20 | 2015-04-01 | 诺和诺德A/S(股份有限公司) | 包含肽和递送剂的片剂制剂 |
US9457096B2 (en) | 2012-07-06 | 2016-10-04 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery |
TWI641381B (zh) * | 2013-02-04 | 2018-11-21 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
EP2991672A1 (en) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
KR20160065126A (ko) | 2013-10-07 | 2016-06-08 | 노보 노르디스크 에이/에스 | 인슐린 유사체의 신규한 유도체 |
AU2015205624A1 (en) | 2014-01-09 | 2016-07-14 | Sanofi | Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives |
AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
PE20210857A1 (es) | 2016-12-16 | 2021-05-18 | Novo Nordisk As | Composiciones farmaceuticas que contienen insulina |
MA53076B1 (fr) | 2018-02-02 | 2023-11-30 | Novo Nordisk As | Compositions solides comportant un agoniste glp-1, du sel d'acide n-(8-(2-hydroxybenzoyl)amino)caprylate et un lubrifiant |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
EP3893934A1 (en) | 2018-12-11 | 2021-10-20 | Sanofi | Insulin conjugates |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3528960A (en) * | 1968-10-07 | 1970-09-15 | Lilly Co Eli | N-carboxyaroyl insulins |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
JPH01254699A (ja) | 1988-04-05 | 1989-10-11 | Kodama Kk | インスリン誘導体及びその用途 |
AU641631B2 (en) | 1988-12-23 | 1993-09-30 | Novo Nordisk A/S | Human insulin analogues |
PT93057B (pt) | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
JP3018463B2 (ja) * | 1989-10-19 | 2000-03-13 | 日本油脂株式会社 | グルコース応答性薬物放出複合体 |
DK10191D0 (da) | 1991-01-22 | 1991-01-22 | Novo Nordisk As | Hidtil ukendte peptider |
US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
US6011007A (en) * | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
CN1056618C (zh) * | 1993-09-17 | 2000-09-20 | 诺沃挪第克公司 | 酰化的胰岛素和含有这种胰岛素的药物组合物 |
US6869930B1 (en) * | 1993-09-17 | 2005-03-22 | Novo Nordisk A/S | Acylated insulin |
US5693609A (en) * | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
JP3872105B2 (ja) * | 1995-03-17 | 2007-01-24 | ノボ ノルディスク アクティーゼルスカブ | インスリン誘導体 |
US6451970B1 (en) * | 1996-02-21 | 2002-09-17 | Novo Nordisk A/S | Peptide derivatives |
ATE278711T1 (de) * | 1996-07-11 | 2004-10-15 | Novo Nordisk As | Verfahren zur selektiven acetylierung |
US5905140A (en) * | 1996-07-11 | 1999-05-18 | Novo Nordisk A/S, Novo Alle | Selective acylation method |
US5898067A (en) * | 1997-02-07 | 1999-04-27 | Novo Nordisk A/S | Crystallization of proteins |
ZA989744B (en) * | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
DE69924232D1 (de) * | 1998-01-09 | 2005-04-21 | Novo Nordisk As | Stabilisierte insulin-zubereitungen |
WO2003013573A1 (en) * | 2001-08-10 | 2003-02-20 | Epix Medical, Inc. | Polypeptide conjugates with extended circulating half-lives |
US8003605B2 (en) * | 2002-03-13 | 2011-08-23 | Novo Nordisk A/S | Minimising body weight gain in insulin treatment |
US20040138099A1 (en) * | 2002-11-29 | 2004-07-15 | Draeger Eberhard Kurt | Insulin administration regimens for the treatment of subjects with diabetes |
WO2005005477A2 (en) * | 2003-07-11 | 2005-01-20 | Novo Nordisk A/S | Stabilised insulin compositions |
AU2004261319B2 (en) | 2003-07-25 | 2010-12-23 | Conjuchem Biotechnologies Inc. | Long lasting insulin derivatives and methods thereof |
EP2264065B1 (en) * | 2003-08-05 | 2017-03-08 | Novo Nordisk A/S | Novel insulin derivatives |
JP2007532096A (ja) | 2003-11-14 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | アシル化されたインスリンの製造方法 |
WO2005047509A2 (en) | 2003-11-14 | 2005-05-26 | University Of Tennessee Research Foundation | The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses |
JP2008506801A (ja) | 2004-07-16 | 2008-03-06 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | 発光性シリコン酸化物フレーク |
WO2006008238A1 (en) | 2004-07-16 | 2006-01-26 | Novo Nordisk A/S | Method for selective acylation |
ES2435522T3 (es) * | 2005-02-02 | 2013-12-20 | Novo Nordisk A/S | Derivados de insulina |
ES2428510T3 (es) * | 2005-02-02 | 2013-11-08 | Novo Nordisk A/S | Derivados de insulina |
DE102005062618B4 (de) | 2005-12-23 | 2008-05-08 | Carl Zeiss Smt Ag | Optische Abbildungseinrichtung und Abbildungsverfahren mit Bestimmung von Abbildungsfehlern |
EP2505593A1 (en) | 2005-12-28 | 2012-10-03 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
ES2387955T3 (es) * | 2006-02-27 | 2012-10-04 | Novo Nordisk A/S | Derivados de insulina |
US20090069215A1 (en) * | 2006-03-13 | 2009-03-12 | Novo Nordisk A/S | Acylated Single Chain Insulin |
JP5269766B2 (ja) * | 2006-05-09 | 2013-08-21 | ノボ・ノルデイスク・エー/エス | インスリン誘導体 |
US9034818B2 (en) * | 2007-06-13 | 2015-05-19 | Novo Nordisk A/S | Pharmaceutical formulations comprising an insulin derivative |
CN101932601B (zh) | 2007-11-08 | 2016-08-03 | 诺沃-诺迪斯克有限公司 | 胰岛素衍生物 |
US8613854B2 (en) | 2007-11-09 | 2013-12-24 | Mann + Hummel Gmbh | Filter element for liquid filters and liquid filter |
WO2010049488A1 (en) | 2008-10-30 | 2010-05-06 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
WO2011141408A2 (de) | 2010-05-10 | 2011-11-17 | Basf Se | Thermoplastisches polyurethan enthaltend glycerin, das mit mindestens einer aliphatischen carbonsäure verestert ist als weichmacher |
EP2569002B1 (en) * | 2010-05-10 | 2016-10-26 | Novo Nordisk A/S | Process for the preparation of insulin-zinc complexes |
-
2007
- 2007-05-08 MX MX2008014061A patent/MX2008014061A/es active IP Right Grant
- 2007-05-08 AU AU2007247109A patent/AU2007247109B2/en not_active Ceased
- 2007-05-08 WO PCT/EP2007/054444 patent/WO2007128817A2/en active Application Filing
- 2007-05-08 US US12/297,911 patent/US8933021B2/en not_active Expired - Fee Related
- 2007-05-08 RU RU2008143668/04A patent/RU2451029C2/ru not_active IP Right Cessation
- 2007-05-08 CA CA002649235A patent/CA2649235A1/en not_active Withdrawn
- 2007-05-08 KR KR1020087027649A patent/KR101441444B1/ko not_active IP Right Cessation
- 2007-05-08 ES ES11160404.7T patent/ES2548393T3/es active Active
- 2007-05-08 JP JP2009508373A patent/JP5269767B2/ja not_active Expired - Fee Related
- 2007-05-08 EP EP07728897A patent/EP2015770B1/en not_active Not-in-force
- 2007-05-08 EP EP11160404.7A patent/EP2386572B1/en not_active Not-in-force
- 2007-05-08 ES ES07728897T patent/ES2395738T3/es active Active
- 2007-05-08 BR BRPI0712041-9A patent/BRPI0712041A2/pt not_active IP Right Cessation
-
2008
- 2008-09-24 IL IL194312A patent/IL194312A0/en unknown
- 2008-12-03 NO NO20085056A patent/NO20085056L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP2386572A1 (en) | 2011-11-16 |
CA2649235A1 (en) | 2007-11-15 |
IL194312A0 (en) | 2011-08-01 |
AU2007247109B2 (en) | 2012-03-15 |
WO2007128817A2 (en) | 2007-11-15 |
EP2386572B1 (en) | 2015-07-08 |
RU2008143668A (ru) | 2010-06-20 |
US20090239785A1 (en) | 2009-09-24 |
ES2395738T3 (es) | 2013-02-14 |
EP2015770A2 (en) | 2009-01-21 |
KR20090018906A (ko) | 2009-02-24 |
WO2007128817A3 (en) | 2008-03-06 |
ES2548393T3 (es) | 2015-10-16 |
JP2009536179A (ja) | 2009-10-08 |
KR101441444B1 (ko) | 2014-09-18 |
JP5269767B2 (ja) | 2013-08-21 |
BRPI0712041A2 (pt) | 2011-12-27 |
AU2007247109A1 (en) | 2007-11-15 |
EP2015770B1 (en) | 2012-09-26 |
MX2008014061A (es) | 2008-11-14 |
RU2451029C2 (ru) | 2012-05-20 |
US8933021B2 (en) | 2015-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085056L (no) | Insulinderivat | |
EP2217596B8 (en) | Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 | |
MX2009009416A (es) | Derivados de bencimidazol y sus metodos de uso. | |
PH12018500767A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
MX2009009417A (es) | Piperidinil-piperidina y piperazinil-piperidina para uso en el tratamiento de diabetes o dolor. | |
NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
EA201100266A1 (ru) | Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные | |
TW200616985A (en) | Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use | |
EA021275B9 (ru) | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания | |
EA201071045A1 (ru) | Соединения оксадиазоантрацена для лечения диабета | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
BR122020010667B8 (pt) | inibidores de quinase, seus usos, e composição farmacêutica | |
EA200800555A1 (ru) | Производные ксантина в качестве селективных агонистов hm74a | |
NO20082709L (no) | Kjemiske forbindelser | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
WO2011044506A3 (en) | Sulphone compounds for use in the treatment of obesity | |
PL381801A1 (pl) | Pochodne mocznika, kompozycje zawierające pochodne mocznika oraz zastosowanie pochodnych mocznika do wytwarzania leku do leczenia skurczowej niewydolności serca | |
WO2008050101A3 (en) | Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk | |
TW200635878A (en) | Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use | |
MX2009004467A (es) | Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk). | |
WO2010071826A3 (en) | Methods for treating osteoclast-related disease, compounds and compositions thereof | |
NO20083905L (no) | Nye pyron-indol derivater og fremgangsmate for deres fremstilling | |
EA200971107A1 (ru) | Катехоламиновые производные, полезные для лечения болезни паркинсона | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
HK1124863A1 (en) | Inhibitors of sodium glucose co-transporter 2 and methods of their use |